This image released by Vatican Governatorato Saturday, May 10, 2025. shows the Pope Leo XIV’s coat of arms. (Vatican Secretariat of State via AP) This composition is the same as the coat of arms ...

What do you need to know? The coat of arms of ...

Office of the Liturgical Celebrations of the Supreme Pontiff (UCEPO) / X This return to traditional elements accompanies Leo’s papal coat of arms. The heraldic design features a fleur-de-lis on ...

The coat of arms of Pope Leo XIV incorporates elements related to Mary and the Augustinian order. Father Antonio Pompili, Vice President of the Italian Institute of Heraldry and Genealogy, explained ...

(THE CONVERSATION) Pope Leo XIV has announced his motto and coat of arms – a long-held tradition for those in the ranks of bishops, cardinals and popes. The choice of symbols and words reflects the ...

HONG KONG, May 8 (Reuters) - U.S. investment firm Bain Capital is seeking to sell the China business of data centre operator WinTriX DC Group, in a deal that could value the business at over $4 ...

Novopor Advanced Science Pvt Ltd, a performance chemicals and material science company controlled by private equity firm Bain Capital, said Wednesday it has acquired a US-based specialty chemicals ...

Bain Capital is expanding its reach into New Jersey’s warehouse sector with a $200 million deal for a portfolio of nearly a dozen properties. The Boston-based private equity firm teamed up with ...

“I’m about to walk into a secure area,” Bain said to Spectrum News during a phone interview before hanging up. In 2020, DeSantis appointed Bain to the 9th Circuit judgeship. He won re ...

Riyadh: Bain & Company joined global stakeholders at the Human Capability Initiative (HCI) 2025 last month in Riyadh, a flagship platform convening policymakers, academics, business leaders, and ...

Insignia Financial Ltd. said Bain Capital has dropped its takeover offer for the Australian wealth firm, but talks are continuing with the remaining bidder, CC Capital Partners. Bain told Insignia ...

(Reuters) -Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the matter.